Drug Type Small molecule drug |
Synonyms- |
Target |
Action agonists |
Mechanism SIRT6 agonists(NAD-dependent protein deacetylase sirtuin-6 agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC20H14BrCl2FN2O6S2 |
InChIKeyMJYYUGUIBHEWRX-UHFFFAOYSA-N |
CAS Registry2275619-55-9 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| disorder of aging | Preclinical | China | 19 Sep 2020 | |
| disorder of aging | Preclinical | China | 19 Sep 2020 | |
| Neoplasms | Preclinical | China | 19 Sep 2020 | |
| Neoplasms | Preclinical | China | 19 Sep 2020 |





